LITIFILIMAB
UNII V27E9V3K7G

Substance Identification & Data

This profile provides standardized clinical and technical data for Litifilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V27E9V3K7G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2407378-48-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

V27E9V3K7G

CAS Registry Number

2407378-48-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LITIFILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C186413

National Cancer Institute reference terminology for clinical and research data.

INN ID

11943

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-165

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Litifilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LITIFILIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN BLOOD DENDRITIC CELL ANTIGEN 2) (HUMAN-MUS MUSCULUS MONOCLONAL BIIB059 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BIIB059 .KAPPA.-CHAIN, DIMER

LITIFILIMAB [INN]

LITIFILIMAB [USAN]

LITIFILIMAB [WHO-DD]